Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;17(1):7-14.
doi: 10.1177/19322968221121152. Epub 2022 Sep 3.

The NIDDK Diabetic Foot Consortium

Teresa L Z Jones  1 , Crystal M Holmes  2 , Aimee Katona  2 , Catherine L Martin  2 , Monika A Niewczas  3 , Rodica Pop-Busui  2 , Brian M Schmidt  2 , Chandan K Sen  4 , Marjana Tomic-Canic  5 , Aristidis Veves  6
Affiliations

The NIDDK Diabetic Foot Consortium

Teresa L Z Jones et al. J Diabetes Sci Technol. 2023 Jan.

Abstract

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Diabetic Foot Consortium (DFC) was established in September 2018 by the NIDDK to build an organization to facilitate the highest quality of clinical research on diabetic foot ulcers (DFUs) that will answer clinically significant questions to improve DFU healing and prevent amputations. The initial focus of the DFC is to develop and validate biomarkers for DFUs that can be used in clinical care and research. The DFC consists of a data coordinating center (DCC) for operational oversight and statistical analysis, clinical sites for participant recruitment and evaluation, and biomarker analysis units (BAUs). The DFC is currently studying biomarkers to predict wound healing and recurrence and is collecting biosamples for future studies through a biorepository. The DFC plans to address the challenges of recruitment and eligibility criteria for DFU clinical trials by taking an approach of "No DFU Patient Goes Unstudied." In this platform approach, clinical history, DFU outcome, wound imaging, and biologic measurements from a large number of patients will be captured and the in-depth longitudinal data set will be analyzed to develop a computational-based DFU risk factor profile to facilitate scientifically sound clinical trial design. The DFC will expand its platform to include studies of the role of social determinants of health, such as food insecurity, housing instability, limited health literacy, and poor social support. The DFC is starting partnerships with the broad group of stakeholders in the wound care community.

Keywords: biomarkers; clinical network; diabetic foot ulcers; diabetic wound healing.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Organization and components of the Diabetic Foot Consortium.
Figure 2.
Figure 2.
Biomarker and biorepository research in the Diabetic Foot Consortium.
Figure 3.
Figure 3.
Current and future activities in the Diabetic Foot Consortium.
See this image and copyright information in PMC

References

    1. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021-1029. - PubMed
    1. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375. - PubMed
    1. Microvascular complications and foot care: Standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S124-S138. - PubMed
    1. Gregg EW, Li Y, Wang J, et al.. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370(16):1514-1523. - PubMed
    1. Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2014;37(3):651-658. - PubMed

Publication types